Defining the Clinical Role of Topiramate in the Treatment of Alcohol Dependence in Australia
Status:
Unknown status
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
To compare the clinical effectiveness, tolerability, and cost-effectiveness of topiramate to
active control (naltrexone) on treatment outcomes for alcohol dependence in a double-blind
randomised controlled trial.
Phase:
Phase 3
Details
Lead Sponsor:
South West Sydney Local Health District
Collaborators:
National Health and Medical Research Council, Australia University of Sydney